The Ah receptor (AhR) is a cytosolic protein which is well studied for its mediation of toxic responses to environmental polyhalogenated aromatic hydrocarbons (PAH) such as dioxin. Our preliminary investigation on the expression of AhR protein in human breast carcinoma (HBC) cell lines has revealed that the AhR is dramatically up-regulated in these cells, in direct proportion to their malignancy. The research we are proposing aims to establish a correlation between the AhR expression and the degree of malignancy in samples of human breast tumors of varying stages of pathogenesis (benign proliferative lesions, ductal carcinoma in situ, invasive mammary carcinoma), in comparison to normal mammary tissue. The expression of AhR mRNA and protein in these specimens will be assessed by in Situ hybridization and immunohistochemical staining, respectively. Results of immunobiochemical analysis will be correlated to the respective histopathological grade and history (clinical stage hormone receptor and lymph node status). The proposed research aims to identify the AhR over-expression as one of the critical determinants in invasion and tumor metastasis cascade by establishing a correlation between its expression and that of these determinants. If well-established, AhR could be used as an independent prognostic, and as an early biomarker for determining the degree for possible early intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA091405-02
Application #
6662110
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-20
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Nichols, Erin E; Richmond, Ann; Daniels, Anthony B (2016) Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma. Semin Ophthalmol 31:304-9
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Ning, Matthew S; Kim, Annette S; Prasad, Nripesh et al. (2014) Characterization of the Merkel Cell Carcinoma miRNome. J Skin Cancer 2014:289548
Seeley, Erin H; Washington, Mary K; Caprioli, Richard M et al. (2013) Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl 7:541-9
M'Koma, Amosy E (2013) Letter to Editor. Adv Enzyme Res 1:77-78
Ochieng, Josiah; Chaudhuri, Gautam (2010) Cystatin superfamily. J Health Care Poor Underserved 21:51-70
Mittal, Mukul K; Myers, Jeremy N; Bailey, Charvann K et al. (2010) Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. Mol Biol Rep 37:1221-7
Zheng, Wei; Cai, Qiuyin; Signorello, Lisa B et al. (2009) Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 18:2761-4
Daikoku, Takiko; Hirota, Yasushi; Tranguch, Susanne et al. (2008) Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 68:5619-27
Daikoku, Takiko; Tranguch, Susanne; Chakrabarty, Anindita et al. (2007) Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res 67:5285-92

Showing the most recent 10 out of 11 publications